期刊文献+

急性粒细胞白血病患儿免疫表型及其临床意义 被引量:3

Immunophenotype of Children with Acute Myeloid Leukemia and Its Clinical Significance
下载PDF
导出
摘要 目的探讨儿童急性粒细胞白血病(AML)免疫分型及其临床意义。方法总结81例儿童AML的免疫表型与FAB分类、1个月骨髓缓解(CR)率及3年无病生存(EFS)率的关系。结果AML儿童1个月CR率为71.6%,3年EFS率为50.8%。HLA-DR缺失,CD34缺失主要见于急性早幼粒细胞白血病(M3)型,阴性患儿CR、EFS率明显高于阳性患儿。CD13阳性患儿的CR明显高于缺失患儿。CD33缺失在M2型中多见,特别是ETO阳性患儿。除外M3病例后分析,CD33缺失患儿的CR率明显高于阳性患者。淋系抗原表达率占34.6%,其中CD7阳性者CR率、EFS率均低于对照组,但无统计学差异。CD56与FAB分型中M2型有显著相关性,其CR率、EFS率均低于对照组。结论HLA-DR、CD34缺失主要见于M3型,是预后良好的指标。CD33缺失多见于M2型中ETO阳性患儿,预后好。淋系抗原、CD56表达多见于M2型,可能是预后差的指标。 Objective To explore the immunophenotype of children with acute myeloid leukemia(AML) and its clinical significance.Methods Statistics was used to analyze the relationship between the immunophenotype of AML and their French-American-Britain(FAB) classification,complete remission (CR) in one month and 3-years event-free survival(EFS).Results CR rate was 71.6% and 3-years EFS rate was 50.8%. HLA-DR and CD34 absent mainly in M3, associated with higher CR and EFS rate. So did CD33 negative cases, especially in M2. CD13 positive was significantly predictive factor for achieving CR.Co-expression of lymphoid antigens and NK cell antigens(CD56) with M2 which correlated with lower CR and EFS rate.Conclusions The negative of HLA-DR, CD34, CD33,as well as CD13 positive, have relationship with good prognosis. Lymphoid antigens and CD56 are poor prognostic factors.
出处 《实用儿科临床杂志》 CAS CSCD 北大核心 2007年第3期206-207,共2页 Journal of Applied Clinical Pediatrics
关键词 儿童 白血病 粒细胞 急性 免疫分型 预后 child,acute myeloid leukemia,immunophenotype,prognosis
  • 相关文献

参考文献11

  • 1王建中.急性白血病免疫学分型及应用[M].上海:上海科学技术出版社,2005:280-290.
  • 2Pereira FG,Metze K,Costa EPS,et al.Phenotypic quantitative features of patients with acute myeloid leukemia[J].Neoplasma,2006,53(2):155-159.
  • 3Mason KD,Juneja SK,Szer J.The immunophenotype of acute myeloid leukemia:Is there a relationship with prognosis[J]?Blood Rev,2006,20:71-82.
  • 4Klobusicka M,Kusenda J,Babusikova O.Myeloid qnzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemial(AML) at diagnosis[J].Neoplasma,2005,52(3):211-217.
  • 5Zeleznikova T,Babusikova O.The value of dot plot patterns and leukemia-associated phenotypes in AML diagnosis by multiparameter flow cytometry[J].Neoplasma,2005,52(6):517-522.
  • 6Florian S,Sonneck K,Hauswirth AW,et al.Detection of molecular targets in the surface of CD34+/CD38-stem cells in various myeloid malignangcies[J].Leuk Lymphoma,2006,47(2):207-222.
  • 7Chang H,Salma F,Yi QI,et al.Prognostic relevance of immunophenotyping in 379 patients with acute myeloid leukemia[J].Leuk Res,2004,28(1):43-48.
  • 8王兴兵,姚军霞,郑金娥,刘隽,李小青,贺艳丽,喻竞明,杨晶,魏君,刘仲萍,黄士昂.115例急性髓细胞白血病多参数流式细胞术免疫表型分析[J].中国实验血液学杂志,2005,13(2):250-253. 被引量:20
  • 9王兴兵,郑金娥,谷俊侠,姚军霞,杨晶,刘隽,李小青,贺艳丽,喻竞明,魏君,刘仲萍,黄士昂.成人急性髓细胞性白血病免疫表型与细胞遗传学及临床特征的关系[J].癌症,2005,24(6):667-671. 被引量:16
  • 10Casanovas RO,Slimane FK,Garand R,et al.Immunological classification of acute myeloblastic leukemia:Relevance to patient outcome[J].Leukemia,2003,17(3):515-527.

二级参考文献18

  • 1Bene MC, Bernier M, Casasnovas RO, et al. The reliability and specificity of c-kit for the diagnosis of acute myeloid leukemias and undifferentiated leukemias. The European Group for the Immunological Classification of Leukemias (EGIL). Blood, 1998; 92: 596 -599.
  • 2Casasnovas RO, Slimane FK, Garand R, et al. Immunological classification of acute myeloblastic leukemias: relevance to patient outcome. Leukemia, 2003; 17:515 - 527.
  • 3Stelzer GT, Goodpasture L. Use of multiparameter flow cytometry and immunophenotyping for the diagnosis and classification of acute myeloid leukemia. In: Stewart CC, Nicholson JKA, eds. Immunophenotyping. New York, NY: Wiley-Liss; 2000:215 - 238.
  • 4Kaleem Z, White G. Diagnostic criteria for minimally differentiated acute myeloid leukemia (AML-M0): evaluation and a proposal. Am J Clin Pathol, 2001; 115:876-884.
  • 5Kaleem Z, Crawford E, Pathan MH, et al. Flow cytometric analysis of acute leukemias. Diagnostic utility and critical analysis of data.Arch Pathol Lab Med, 2003; 127:42 -48.
  • 6Paietta E. Expression of cell-surface antigens in acute promyelocytic leukaemia. Best Pract Res Clin Haematol, 2003; 16:369 - 385.
  • 7Auewarakul CU, Promsuwicha O, U-Pratya Y, et al. Immunophenotypic profile of adult acute myeloid leukemia (AML): analysis of 267 cases in Thailand. Asian Pac J Allergy Immunol, 2003; 21:153 -160.
  • 8Khalidi HS, Medeiros LJ, Chang KL, et al. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities[J]. Am J Clin Pathol, 1998,109(2) :211-220.
  • 9Paietta E. Expression of cell-surface antigens in acute promyelocytic leukaemia[J]. Best Pract Res Clin Haematol,2003,16(3) :369-385.
  • 10Casasnovas RO, Campos L, Mugneret F, et al. Immunophenotypic patterns and cytogenetic anomalies in acute nonlymphoblastic leukemia subtypes: a prospective study of 432patients[J]. Leukemia, 1998,12(1): 34-43.

共引文献34

同被引文献13

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部